Yoheenee Jugdoyal*

BSc Biotechnology, Johannesburg, South Africa

*Corresponding Author: Yoheenee Jugdoyal, BSc Biotechnology, Johannesburg, South Africa.

Received: August 29, 2023; Published: October 19, 2023

Abstract

A disease which is characterised by memory loss, change in behaviour and thinking patterns. Alzheimer’s disease is neurodegenerative and progressive. It is one of the most common causes of dementia and causes irreversible damage to the brain.

 Keywords: Alzheimer’s Disease; Brain; Cell

References

1. Wang MQ., et al. “Research progress of genetics of Alzheimer’s disease”. Chinese Journal of Rehabilitation Theory and Practice13 (2015).
2. Gauthier S., et al. “Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer’s disease: A randomised, controlled, double-blind, parallel-arm, phase 3 trial”. Lancet 10062 (2016): 2873-2884.
3. Hunter TA. “Replication of CLU, CR1, and PICALM associations with Alzheimer disease”.Archives of Neurology 8 (2010): 961-964.

Citation

Citation: Yoheenee Jugdoyal. “What is Alzheimer’s Disease?”.Acta Scientific Medical Sciences 7.11 (2023): 81-82.

Copyright

Copyright: © 2023 Yoheenee Jugdoyal. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.